About (3E)-1-[(R)-(4-fluorophenyl)-[(2S)-oxolan-2-yl]methyl]-3-[[3-methoxy-4-(5-methyl-1H-imidazol-2-yl)phenyl]methylidene]piperidin-2-one
(3E)-1-[(R)-(4-fluorophenyl)-[(2S)-oxolan-2-yl]methyl]-3-[[3-methoxy-4-(5-methyl-1H-imidazol-2-yl)phenyl]methylidene]piperidin-2-one (PubChem CID 67549874) has the molecular formula C28H30FN3O3
and a molecular weight of 475.56 g/mol. Its IUPAC name is (3E)-1-[(R)-(4-fluorophenyl)-[(2S)-oxolan-2-yl]methyl]-3-[[3-methoxy-4-(5-methyl-1H-imidazol-2-yl)phenyl]methylidene]piperidin-2-one.
Molecular Properties
| Compound Name | (3E)-1-[(R)-(4-fluorophenyl)-[(2S)-oxolan-2-yl]methyl]-3-[[3-methoxy-4-(5-methyl-1H-imidazol-2-yl)phenyl]methylidene]piperidin-2-one |
| PubChem CID | 67549874 |
| Molecular Formula | C28H30FN3O3 |
| Molecular Weight | 475.56 g/mol |
| Exact Mass | 475.23 |
| IUPAC Name | (3E)-1-[(R)-(4-fluorophenyl)-[(2S)-oxolan-2-yl]methyl]-3-[[3-methoxy-4-(5-methyl-1H-imidazol-2-yl)phenyl]methylidene]piperidin-2-one |
| SMILES | COc1cc(/C=C2\CCCN([C@H](c3ccc(F)cc3)[C@@H]3CCCO3)C2=O)ccc1-c1ncc(C)[nH]1 |
| InChI | InChI=1S/C28H30FN3O3/c1-18-17-30-27(31-18)23-12-7-19(16-25(23)34-2)15-21-5-3-13-32(28(21)33)26(24-6-4-14-35-24)20-8-10-22(29)11-9-20/h7-12,15-17,24,26H,3-6,13-14H2,1-2H3,(H,30,31)/b21-15+/t24-,26+/m0/s1 |
| InChIKey | USBPHOJMCDTQNI-PLUOYHTPSA-N |
| XLogP | 5.46 |
| TPSA | 67.45 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 475.56 |
| LogP ≤ 5 | 5.46 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Analyze (3E)-1-[(R)-(4-fluorophenyl)-[(2S)-oxolan-2-yl]methyl]-3-[[3-methoxy-4-(5-methyl-1H-imidazol-2-yl)phenyl]methylidene]piperidin-2-one with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of (3E)-1-[(R)-(4-fluorophenyl)-[(2S)-oxolan-2-yl]methyl]-3-[[3-methoxy-4-(5-methyl-1H-imidazol-2-yl)phenyl]methylidene]piperidin-2-one?
The IUPAC name of (3E)-1-[(R)-(4-fluorophenyl)-[(2S)-oxolan-2-yl]methyl]-3-[[3-methoxy-4-(5-methyl-1H-imidazol-2-yl)phenyl]methylidene]piperidin-2-one (CID 67549874) is (3E)-1-[(R)-(4-fluorophenyl)-[(2S)-oxolan-2-yl]methyl]-3-[[3-methoxy-4-(5-methyl-1H-imidazol-2-yl)phenyl]methylidene]piperidin-2-one.
What is the SMILES notation for (3E)-1-[(R)-(4-fluorophenyl)-[(2S)-oxolan-2-yl]methyl]-3-[[3-methoxy-4-(5-methyl-1H-imidazol-2-yl)phenyl]methylidene]piperidin-2-one?
The canonical SMILES for (3E)-1-[(R)-(4-fluorophenyl)-[(2S)-oxolan-2-yl]methyl]-3-[[3-methoxy-4-(5-methyl-1H-imidazol-2-yl)phenyl]methylidene]piperidin-2-one is COc1cc(/C=C2\CCCN([C@H](c3ccc(F)cc3)[C@@H]3CCCO3)C2=O)ccc1-c1ncc(C)[nH]1.
What is the InChIKey of (3E)-1-[(R)-(4-fluorophenyl)-[(2S)-oxolan-2-yl]methyl]-3-[[3-methoxy-4-(5-methyl-1H-imidazol-2-yl)phenyl]methylidene]piperidin-2-one?
The InChIKey is USBPHOJMCDTQNI-PLUOYHTPSA-N. The full InChI is InChI=1S/C28H30FN3O3/c1-18-17-30-27(31-18)23-12-7-19(16-25(23)34-2)15-21-5-3-13-32(28(21)33)26(24-6-4-14-35-24)20-8-10-22(29)11-9-20/h7-12,15-17,24,26H,3-6,13-14H2,1-2H3,(H,30,31)/b21-15+/t24-,26+/m0/s1.
What are the key properties of (3E)-1-[(R)-(4-fluorophenyl)-[(2S)-oxolan-2-yl]methyl]-3-[[3-methoxy-4-(5-methyl-1H-imidazol-2-yl)phenyl]methylidene]piperidin-2-one?
(3E)-1-[(R)-(4-fluorophenyl)-[(2S)-oxolan-2-yl]methyl]-3-[[3-methoxy-4-(5-methyl-1H-imidazol-2-yl)phenyl]methylidene]piperidin-2-one has a molecular weight of 475.56 g/mol, XLogP of 5.46, 6 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (3E)-1-[(R)-(4-fluorophenyl)-[(2S)-oxolan-2-yl]methyl]-3-[[3-methoxy-4-(5-methyl-1H-imidazol-2-yl)phenyl]methylidene]piperidin-2-one is sourced from PubChem (CID 67549874), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).